Ginkgo biloba not useful in preventing dementia

NEW YORK (Reuters Health) - Although often billed as a memory and cognition enhancing product, the medicinal herb Ginkgo biloba does not stave off cognitive decline or help prevent dementia and Alzheimer’s disease, according to a report in the Journal of the American Medical Association this week.

In the Ginkgo Evaluation of Memory (GEM) Study, use of the herbal product was actually tied to higher risks of dementia and Alzheimer’s disease, but the associations did not reach statistical significance.

“Ginkgo biloba is widely used for its potential effects on memory and cognition,” Dr. Steven T. DeKosky, from the University of Virginia School of Medicine, Charlottesville, and colleagues note. However, “to date, adequately powered clinical trials testing the effect of Ginkgo biloba on dementia incidence are lacking.”

In the GEM study, 2,587 older adults (75 years of age and older) with normal cognition and 482 with mild cognitive impairment were allocated to receive a twice-daily dose of Gingko biloba extract (120 milligrams) or placebo.

The researchers found no statistical difference in rates of dementia or Alzheimer’s disease between the two groups. Overall, 277 subjects taking Ginkgo and 246 subjects taking placebo developed dementia over the course of the study, which lasted a median of about 6 years.

Compared with placebo, Ginkgo use was associated with a slightly increased risk of dementia and Alzheimer’s disease.

There was also no evidence that Ginkgo use reduced progression to dementia in subjects with mild cognitive impairment.

This study, wrote Dr. Lon S. Schneider in an editorial in the journal, “adds to the substantial body of evidence that Gingko biloba extract as it is generally used does not prevent dementia in individuals with or without cognitive impairment and is not effective for Alzheimer’s disease.”

“Users of this extract should not expect it to be helpful,” continued Schneider, who is with the University of Southern California, Los Angeles.

Moreover, the potential adverse effects of Gingko biloba extract, Schneider points out, including stroke or “mini-strokes,” illustrate why it is “untenable to recommend a drug or nutriceutical in the absence of efficacy evidence simply because it could possibly help and initially appears harmless.”

SOURCE: Journal of the American Medical Association, November 19, 2008.


Related Posts:

By Will Dunham WASHINGTON (Reuters) - The widely used herbal supplement Ginkgo biloba does not appear to prevent Alzheimer’s disease in healthy elderly people or those with mild cognitive impairment, U.S. researchers said on Tuesday. The study involved 3,069 people age 75 or older at five U.S. locations who were tracked for six years on average, half

Full Post: Herbal supplement Ginkgo doesn’t stop Alzheimer’s

LONDON (Reuters) - Mentally demanding jobs and more education appear to protect people from the memory loss associated with Alzheimer’s disease, Italian researchers said on Monday. The findings bolster the previous research about Alzheimer’s and other forms of brain impairment, said Valentina Garibotto of the San Raffaele University and Scientific Institute and the National Institute of

Full Post: Education protects against Alzheimer’s impact

By Will Dunham WASHINGTON (Reuters) - High doses of B vitamins failed to slow cognitive decline in people with Alzheimer’s disease, dashing the hopes for a new weapon against the fatal, mind-robbing ailment, U.S. researchers said on Tuesday. Experts had viewed B vitamins as a potential way to lower the risk of Alzheimer’s disease or slow its

Full Post: B vitamins fail in U.S. Alzheimer’s disease study

By Will Dunham WASHINGTON (Reuters) - Brain scans of people with an abnormality that is a hallmark of Alzheimer’s disease are strengthening the notion that greater education levels somehow protect against this common form of dementia. People with more education did better on memory and problem solving tests than others with similar amounts of brain plaques related

Full Post: Education blunts effects of Alzheimer’s: study

NEW YORK (Reuters Health) - New research shows that among the mental abilities that are affected by type 2 diabetes, the speed at which the brain processes information appears to be the most severely impaired, particularly in patients with undiagnosed disease. Findings from several studies have linked type 2 diabetes with cognitive dysfunction. However, it was

Full Post: Type 2 diabetes may slow mental processing speed

Site Navigation

Most Read